The General Data Protection Regulation and Its Impact on Clinical Research

The General Data Protection Regulation (GDPR) entered into force on 25 May 2016, and has been applicable since 25 May 2018, introducing important changes impacting the collection and use of data for all sectors including scientific research across the European Union (EU). Three years since the Regulation became applicable, and in view of the direct impact the GDPR has had on research, the European Society for Medical Oncology (ESMO) in association with the MEPs Against Cancer (MAC) Interest Group at the European Parliament, convened a virtual meeting on the GDPR and its impact on clinical research.

Speakers included:

• Owe Langfeldt, European Commission
• Alessandra Moretti, MEP
• Peter Liese, MEP
• Tomislav Sokol, MEP
• Sabine Brosch & Orsolya Eotvos, European Medicines Agency (EMA)
• Annalisa Trama, European Reference Network on Rare Adult Solid Cancers (ERN EURACAN)
• Rosa Giuliani, European Society for Medical Oncology (ESMO)

In association with: